Home »
Academic Articles »
C »
Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases
Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases
Li Tao
(Emergency Department, 305 Hospital of People’s Liberation Army, Beijing 100017, China)
Xiaomeng Ren
(College of Pharmaceutical and Biology Engineering, Shenyang University of Chemical Technology, Shenyang 110142, China)
Wenhui Zhai
(Emergency Department, 305 Hospital of People’s Liberation Army, Beijing 100017, China)
Zheng Chen
(HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China)
Journal: Molecules
•
• MDPI AG
• ISSN: 1420-3049
Abstract
Non-canonical nuclear factor kappa B (NF-κB) signaling pathway regulates many physiological and pathological processes, including liver homeostasis and diseases. Recent studies demonstrate that non-canonical NF-κB signaling pathway plays an essential role in hyperglycemia, non-alcoholic fatty liver disease, alcoholic liver disease, liver regeneration, liver injury, autoimmune liver disease, viral hepatitis, and hepatocellular carcinoma. Small-molecule inhibitors targeting to non-canonical NF-κB signaling pathway have been developed and shown promising results in the treatment of liver injuries. Here, the recent advances and future prospects in understanding the roles of the non-canonical NF-κB signaling pathways in the regulation of liver diseases are discussed.
Li Tao, Xiaomeng Ren, Wenhui Zhai, et al. (2022). "Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases". Molecules. https://doi.org/10.3390/molecules27134275